Evidence map›Paper›PMID 18482867›Full record

Trial reportSleep medicine2009

A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia.

Diana M Taibi, Michael V Vitiello, Suzanne Barsness, Gary W Elmer, Gail D Anderson, Carol A Landis

Registry-linked trialAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Sleep medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00097604 (Valerian for Sleep Disturbance in Healthy Older Adults), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00097604 phase2completednot on this map

Valerian for Sleep Disturbance in Healthy Older Adults

TypeinterventionalSponsorUniversity of WashingtonRan2004 to 2008Enrolled18ConditionsSleep Initiation and Maintenance DisordersArmsValerian root extract
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Pharmaceutical biology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Effect ofPrzeglad menopauzalny = Menopause review · 2017
    Article
  16. Article
  17. Article
  18. Concordance of polysomnographic and actigraphic measurement of sleep and wake in older women with insomnia.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2013
    Article
  19. The effect of hydro-alcohol extract ofJournal of family medicine and primary care
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Diana M TaibiDepartment of Biobehavioral Nursing & Health Systems, School of Nursing, University of Washington, Box 357266, Seattle, WA 98195-7262, USA.
Michael V Vitiello
Suzanne Barsness
Gary W Elmer
Gail D Anderson
Carol A Landis

Funding

WOMENS HEALTH--NURSING RESEARCH TRAININGT32NR007039 · NINR · UNIVERSITY OF WASHINGTON · PI KILLIEN, MARCIA G · 1987 to 2007
$2.9M
Valerian for Sleep Disturbance in Healthy Older AdultsR21AT002108 · NCCIH · UNIVERSITY OF WASHINGTON · PI LANDIS, CAROL A · 2004 to 2005
$379k
NCCIH NIH HHS AT002108NCCIH NIH HHS R21 AT002108NINR NIH HHS NR04011NINR NIH HHS T32 NR007039NINR NIH HHS T32 NR07039-18
6 · The paper itself

Abstract

objectiveTo test the effects of nightly valerian (Valeriana officinalis) extract to improve sleep of older women with insomnia.

methodsParticipants in this phase 2 randomized, double-blind, crossover controlled trial were 16 older women (mean age=69.4+/-8.1 years) with insomnia. Participants took 300 mg of concentrated valerian extract or placebo 30 min before bedtime for 2 weeks. Sleep was assessed in the laboratory by self-report and polysomnography (PSG) at baseline and again at the beginning and end of each treatment phase (total of nine nights in the laboratory) and at home by daily sleep logs and actigraphy.

resultsThere were no statistically significant differences between valerian and placebo after a single dose or after 2 weeks of nightly dosing on any measure of sleep latency, wake after sleep onset (WASO), sleep efficiency, and self-rated sleep quality. In comparing each treatment to baseline in separate comparisons, WASO significantly increased (+17.7+/-25.6 min, p=.02) after 2 weeks of nightly valerian, but not after placebo (+6.8+/-26.4 min, NS). Side effects were minor and did not differ significantly between valerian and placebo.

conclusionValerian did not improve sleep in this sample of older women with insomnia. Findings from this study add to the scientific evidence that does not support use of valerian in the clinical management of insomnia.

Indexed as

PhytotherapyValerianAgedAgingCross-Over StudiesFemaleHumansMiddle AgedMonitoring, PhysiologicPlacebosPlant ExtractsPolysomnographySleepSleep Initiation and Maintenance DisordersTreatment FailurePlacebosPlant Extracts

Identifiers

PMID18482867
PMCPMC2709274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.